New York company with an automated IVF laboratory platform (AURA) based on robotics and AI.
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Series A Conceivable Life Sciences raised $50 million in a Series A led by Advance Venture Partners for its automated IVF laboratory AURA. | $50M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.